We are live on ! Find out more
LLY icon

Eli Lilly

1,005 hedge funds and large institutions have $42.1B invested in Eli Lilly in 2013 Q4 according to their latest regulatory filings, with 112 funds opening new positions, 341 increasing their positions, 406 reducing their positions, and 69 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more first-time investments, than exits

New positions opened: 112 | Existing positions closed: 69

11% more call options, than puts

Call options by funds: $460M | Put options by funds: $416M

3% more funds holding

Funds holding: 9741,005 (+31)

2% more capital invested

Capital invested by funds: $41.1B → $42.1B (+$950M)

0.62% more ownership

Funds ownership: 72.69%73.31% (+0.62%)

16% less repeat investments, than reductions

Existing positions increased: 341 | Existing positions reduced: 406

17% less funds holding in top 10

Funds holding in top 10: 2319 (-4)

Holders
1,005
Holders Change
+31
Holders Change %
+3.18%
% of All Funds
29.16%
Holding in Top 10
19
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-17.39%
% of All Funds
0.55%
New
112
Increased
341
Reduced
406
Closed
69
Calls
$460M
Puts
$416M
Net Calls
+$44.3M
Net Calls Change
-$109M
Name Holding Trade Value Shares
Change
Change in
Stake
SO
126
STRS Ohio
Ohio
$34.9M +$1.6M +31,900 +5%
Two Sigma Advisers
127
Two Sigma Advisers
New York
$34.4M +$19.5M +388,668 +136%
KBC Group
128
KBC Group
Belgium
$34.3M +$6.52M +130,189 +24%
BCIM
129
British Columbia Investment Management
British Columbia, Canada
$34M -$843K -16,838 -2%
Aviva
130
Aviva
United Kingdom
$33.9M +$4.12M +82,249 +14%
JIR
131
James Investment Research
Ohio
$33.1M +$2.44M +48,802 +8%
PFC
132
Poplar Forest Capital
California
$32.5M +$2.05M +40,845 +7%
RAM
133
RWC Asset Management
United Kingdom
$32.4M +$4.06M +80,989 +15%
ONB
134
Old National Bancorp
Indiana
$32.4M -$1.13M -22,549 -3%
Robeco Institutional Asset Management
135
Robeco Institutional Asset Management
Netherlands
$32.3M +$315K +6,297 +1%
PAMU
136
Pictet Asset Management (UK)
United Kingdom
$32.1M +$30K +600 +0.1%
MLICM
137
Metropolitan Life Insurance Company (MetLife)
New York
$31.8M +$124K +2,480 +0.4%
GF
138
Gabelli Funds
New York
$31.5M -$250K -5,000 -0.8%
VRS
139
Virginia Retirement Systems
Virginia
$31.2M -$6.73M -134,354 -18%
LBG
140
Lloyds Banking Group
United Kingdom
$31M +$2.15M +42,883 +8%
FRM
141
Foundation Resource Management
Arkansas
$30.9M +$298K +5,957 +1%
HI
142
Honeywell International
North Carolina
$30.6M +$22.5M +450,000 +300%
TRSOTSOK
143
Teachers Retirement System of the State of Kentucky
Kentucky
$30.3M -$6.64M -132,610 -18%
Canada Pension Plan Investment Board
144
Canada Pension Plan Investment Board
Ontario, Canada
$30.2M -$1.39M -27,792 -4%
Retirement Systems of Alabama
145
Retirement Systems of Alabama
Alabama
$30.1M +$33.3K +664 +0.1%
SCP
146
Seizert Capital Partners
Michigan
$30M +$3.32M +66,264 +13%
USAA
147
United Services Automobile Association
Texas
$28.9M -$13.4M -267,978 -32%
CCMH
148
Cornerstone Capital Management Holdings
New York
$28.8M +$9.56M +190,845 +51%
SAM
149
Shell Asset Management
Netherlands
$28.7M +$3.4M +67,977 +14%
NG
150
NatWest Group
United Kingdom
$28.6M +$2.81M +56,066 +11%

LLY Hedge Fund Activity: Q4 2013 in Review

1,005 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q4 2013, worth a combined $42.1B — up 2.3% from $41.1B a quarter earlier.

Buyers outnumbered sellers: 112 funds opened new LLY positions and 69 closed out — a net gain of 43 holders — while 341 added to existing stakes and 406 trimmed.

The largest buyer was Franklin Resources, adding an estimated $711M. The largest seller was Fidelity Investments, cutting an estimated $141M.

  • 1,005 institutional investors held Eli Lilly (LLY) as of Q4 2013, up from 974 in Q3 2013.
  • Funds reported $42.1B of Eli Lilly stock for Q4 2013, up 2.3% quarter-over-quarter.
  • 112 funds opened new Eli Lilly positions in Q4 2013 and 69 closed out, a net change of +43 holders.
  • The largest Eli Lilly buyer in Q4 2013 was Franklin Resources, an estimated $711M added.
  • The largest Eli Lilly seller in Q4 2013 was Fidelity Investments, an estimated $141M sold.

Based on aggregated 13F filings for Q4 2013.